All in the Family: The Growth Hormone, Prolactin, and Placental Lactogen Triad

1993 ◽  
pp. 1-9
Author(s):  
Henry G. Friesen
1981 ◽  
Vol 256 (1) ◽  
pp. 296-300
Author(s):  
J. Russell ◽  
L.M. Sherwood ◽  
K. Kowalski ◽  
A.B. Schneider

1972 ◽  
Vol 50 (10) ◽  
pp. 1014-1017
Author(s):  
Catherine L. Tanser ◽  
Nannie K. M. de Leeuw

The effect of human growth hormone (HGH) and human placental lactogen (HPL) on glucose consumption by erythrocytes and leucocytes in vitro was investigated. Glucose consumption was measured by determining glucose utilization during 3 h incubation at 37 °C, using the glucose oxidase method.HGH and HPL showed no effect on glucose consumption by erythrocytes, and HPL showed no effect on glucose consumption by leucocytes in vitro. Our results do not confirm previous reports of an inhibitory effect of HGH on glucose consumption by erythrocytes in vitro.


1998 ◽  
pp. 461-490 ◽  
Author(s):  
Russell V. Anthony ◽  
Sean W. Limesand ◽  
Michael D. Fanning ◽  
Rongti Liang

1988 ◽  
pp. 33-57
Author(s):  
Hugo A. Barrera-Saldanña ◽  
Ramiro Ramírez-Solís ◽  
William H. Walker ◽  
Susan L. Fitzpatrick ◽  
Diana Reséndez-Pérez ◽  
...  

1999 ◽  
Vol 30 (10) ◽  
pp. 1201-1206 ◽  
Author(s):  
Peter Berger ◽  
Gerold Untergasser ◽  
Martin Hermann ◽  
Anton Hittmair ◽  
Stephan Madersbacher ◽  
...  

1995 ◽  
Vol 144 (1) ◽  
pp. 75-82 ◽  
Author(s):  
B W Gallaher ◽  
B H Breier ◽  
W F Blum ◽  
S N McCutcheon ◽  
P D Gluckman

Abstract Although insulin-like growth factor-binding protein-2 (IGFBP-2) is an abundant IGFBP in fetal and postnatal plasma, its regulation is not yet clearly understood. To address this question in sheep, we purified ovine IGFBP-2 and developed a homologous radioimmunoassay. We have studied its ontogenesis and measured serum concentrations of ovine IGFBP-2 after bovine growth hormone (bGH), ovine placental lactogen (oPL) and IGF-I treatment. Concentrations of IGFBP-2 were high at 125 days of gestation (550 ± 15 μg/l) but fell after birth P<0·05) and plateaued after 1 year of age (340 ± 20 μg/l). In lactating ewes, bGH treatment for 7 days significantly reduced (21%; P<0·05) IGFBP-2 relative to the saline-treated group. Similarly, in neonatal lambs, bGH treatment from day 3 to day 23 of life reduced (P<0·05) IGFBP-2 by 23% relative to the saline-treated group. oPL had no effect on serum levels of IGFBP-2 in the ewe or the neonatal lamb. In well-fed yearling lambs, treatment with IGF-I reduced IGFBP-2 values by 27% (P<0·05) relative to control animals. In yearling lambs, reduced nutrition increased plasma IGFBP-2 (41%; P<0·05). However this increase was abolished by IGF-I treatment. The changes in plasma levels of IGFBP-2 were positively related to changes in IGF-II while there was a negative relationship between circulating IGF-I and IGFBP-2 such that both IGF-I and IGF-II may play a role in the regulation of IGFBP-2 in serum. Journal of Endocrinology (1995) 144, 75–82


Endocrinology ◽  
1979 ◽  
Vol 105 (4) ◽  
pp. 905-910 ◽  
Author(s):  
G. T. CAMPBELL ◽  
J. WAGONER ◽  
K. A. GREGERSON ◽  
W. L. JOYNER

Sign in / Sign up

Export Citation Format

Share Document